Harvard: The 4-Year Study That Froze Aging For 3 Years | Dr JoAnn Manson

MEDICAL DISCLAIMER: Modern Healthspan provides reports on peer-reviewed longevity research. We do not provide medical advice, diagnosis, or treatment. The clinical findings presented by Dr. JoAnn Manson from the VITAL trial are for informational use only. Please see your physician before starting 2,000 IU of Vitamin D or any other supplement protocol. Harvard Professor Dr. JoAnn Manson reveals the final results of the VITAL trial: a landmark study on Vitamin D, telomeres, and disease prevention. Some links are affiliate links so we will earn a commission when they are used to purchase products. If you would like to support our channel please consider joining our Patreon https://patreon.com/ModernHealthspan ~~~~~~~~~~~~~~ *Seeking Health* (10% off: Richard10) D3/K2 Drops https://crrnt.app/SEEK/P8Mz8R23, D3 Drops https://crrnt.app/SEEK/NqMLKkDe *Renue By Science* (10% off: MHS) https://tinyurl.com/yu7zs864 *ProHealth* (15% off: MODERN) https://prohealth.pxf.io/9gVX3e Vitamin D3 + K2 *OmegaQuant* (5% off: MODERN) https://omegaquant.com/ref/500/ - Omega 3 blood level test ~~~~~~~~~~~~~~ Is Vitamin D the most underrated molecule in longevity science? Dr. JoAnn Manson, Professor of Medicine at Harvard Medical School and lead investigator of the massive VITAL trial, joins us to present groundbreaking new data. We move past the traditional focus on bone health to explore how 2,000 IU of Vitamin D preserves telomere length, effectively slowing biological aging by three years. Dr. Manson discusses the 22% reduction in autoimmune diseases and the 17% reduction in advanced metastatic cancers found within the 25,000-participant study. We also tackle the "BMI Gap", the critical reason why Vitamin D benefits are often blunted in certain populations, and the importance of the Vitamin D/Omega-3 synergy. This conversation provides a definitive clinical roadmap for anyone using these supplements to extend their healthspan. Rooted in gold-standard randomized controlled trial data, this is an essential update on the science of aging well. *RESEARCH NOTICE*: This video features a discussion on emerging clinical data from the VITAL trial and is intended for educational and informational purposes only. The findings regarding Vitamin D and biological aging are based on large-scale population studies and do not constitute an endorsement or medical recommendation for any specific individual. Scientific consensus can evolve, and the application of any research discussed is at the viewer's own risk. Always consult with a healthcare professional before making changes to your diet, supplement, or exercise routine. 📚 Chapters 0:00 – Introduction: The VITAL Trial Overview 4:56 – The 2025 Telomere & Biological Age Study 12:15 – Cancer Prevention: Reduction in Metastatic Risk 20:40 – Vitamin D and Heart Health: The Nuanced Results 25:10 – The BMI "Gatekeeper": Why Body Fat Matters 32:15 – 22% Reduction in Autoimmune Diseases 42:30 – Omega-3s vs. Vitamin D: Which is More Potent? 48:10 – Final Recommendations & Safe Dosages 🌐Links in this video The VITAL Study home page: https://www.vitalstudy.org/ 🔬 Peer-Reviewed Research Cited 1. The Autoimmune Breakthrough (VITAL Trial) Title: Vitamin D and marine omega 3 fatty acid supplementation and incidence of autoimmune disease: VITAL randomized controlled trial Journal: The BMJ DOI: 10.1136/bmj-2021-066452 PubMed: 38272846 Impact: This landmark study of 25,871 participants demonstrated that five years of Vitamin D supplementation (2000 IU/day) resulted in a 22% lower rate of confirmed autoimmune disease. 2. The Telomere & Biological Aging Analysis Title: Vitamin D Supplementation and Leucocyte Telomere Length in the VITAL Trial Journal: The American Journal of Clinical Nutrition (AJCN) PubMed: 40409468 Impact: An ancillary study showing that 2,000 IU of Vitamin D daily significantly buffered telomere shortening over time, effectively preserving the equivalent of three years of biological aging compared to the placebo group. 3. The Cancer Metastasis Discovery Title: Vitamin D supplementation and total cancer incidence and mortality: the Vitamin D and OmegA-3 TriaL (VITAL) Journal: The American Journal of Clinical Nutrition (AJCN) DOI: 10.1093/ajcn/nqy135 PubMed: 21986389 Impact: This analysis revealed that while total cancer incidence did not drop significantly, Vitamin D supplementation was associated with a 17% reduction in advanced (metastatic or fatal) cancers. #Longevity #VitaminD #BiologicalAge